- Home
- EMF vs ANIK Comparison
EMF vs ANIK Comparison
Compare EMF & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EMF | ANIK |
|---|---|---|
| Founded | 1987 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 254.5M | 142.5M |
| IPO Year | N/A | 1993 |
Fundamental Metrics
Financial Performance| Metric | EMF | ANIK |
|---|---|---|
| Price | $17.56 | $9.57 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $16.00 |
| AVG Volume (30 Days) | 29.3K | ★ 182.3K |
| Earning Date | 01-01-0001 | 11-05-2025 |
| Dividend Yield | ★ 6.16% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $112,806,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.79 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 30.55 |
| 52 Week Low | $10.58 | $7.87 |
| 52 Week High | $12.67 | $18.37 |
Technical Indicators
Market Signals| Indicator | EMF | ANIK |
|---|---|---|
| Relative Strength Index (RSI) | 61.08 | 47.89 |
| Support Level | $17.43 | $9.48 |
| Resistance Level | $17.78 | $9.75 |
| Average True Range (ATR) | 0.22 | 0.26 |
| MACD | 0.08 | -0.03 |
| Stochastic Oscillator | 82.44 | 24.05 |
Price Performance
Historical ComparisonAbout EMF Templeton Emerging Markets Fund
Templeton Emerging Markets Fund is a closed-end management investment company. It seeks long-term capital appreciation by investing, under normal market conditions, at least 80% of its net assets in emerging country equity securities. It invests in various sectors such as Pharmaceuticals, Beverages, Broadline Retail, Metals &Mining, Banks, Food Products, Semiconductors & Semiconductor Equipment, insurance, Entertainment, and others.
About ANIK Anika Therapeutics Inc.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.